Precigen Net Income from 2010 to 2026
| PGEN Stock | USD 4.53 0.07 1.57% |
Net Loss | First Reported 2012-03-31 | Previous Quarter -26.6 M | Current Value -146.3 M | Quarterly Volatility 54.4 M |
Check Precigen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precigen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.9 M, Interest Expense of 6.6 K or Total Revenue of 3.4 M, as well as many indicators such as Price To Sales Ratio of 72.19, Dividend Yield of 0.0 or PTB Ratio of 4.58. Precigen financial statements analysis is a perfect complement when working with Precigen Valuation or Volatility modules.
Precigen | Net Income | Build AI portfolio with Precigen Stock |
Evaluating Precigen's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Precigen's fundamental strength.
Latest Precigen's Net Income Growth Pattern
Below is the plot of the Net Income of Precigen over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Precigen financial statement analysis. It represents the amount of money remaining after all of Precigen operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Precigen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Precigen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (126.23 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Precigen Net Income Regression Statistics
| Arithmetic Mean | (125,331,093) | |
| Geometric Mean | 104,809,255 | |
| Coefficient Of Variation | (88.59) | |
| Mean Deviation | 63,125,828 | |
| Median | (95,904,000) | |
| Standard Deviation | 111,026,667 | |
| Sample Variance | 12326.9T | |
| Range | 537.7M | |
| R-Value | (0.07) | |
| Mean Square Error | 13084.9T | |
| R-Squared | 0 | |
| Significance | 0.79 | |
| Slope | (1,531,831) | |
| Total Sum of Squares | 197230.7T |
Precigen Net Income History
Other Fundumenentals of Precigen
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Precigen Net Income component correlations
About Precigen Financial Statements
Precigen investors utilize fundamental indicators, such as Net Income, to predict how Precigen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -113.6 M | -119.3 M | |
| Net Loss | -145.2 M | -152.4 M | |
| Net Income Applicable To Common Shares | 32.6 M | 34.2 M | |
| Net Loss | (0.42) | (0.45) | |
| Net Income Per E B T | 1.13 | 1.05 |
Pair Trading with Precigen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.Moving against Precigen Stock
| 0.58 | ZBIO | Zenas BioPharma Common | PairCorr |
| 0.5 | SNGX | Soligenix | PairCorr |
| 0.37 | ENSC | Ensysce Biosciences | PairCorr |
The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.
The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Precigen Correlation against competitors. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Biotechnology sector continue expanding? Could Precigen diversify its offerings? Factors like these will boost the valuation of Precigen. Anticipated expansion of Precigen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Precigen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth 0.194 | Return On Assets | Return On Equity |
Investors evaluate Precigen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Precigen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Precigen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Precigen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precigen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Precigen's market price signifies the transaction level at which participants voluntarily complete trades.